July 2, 2012

Increasing one's caffeinated coffee intake could lower one's risk of developing basal cell carcinoma — which is considered the most common form of skin cancer — according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

April 27, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline for certain cancer patients.

March 21, 2012

A Food and Drug Administration expert panel delivered a favorable vote on a cancer drug made by GlaxoSmithKline.